TELETRADER News
1/19, 11:48 AM (Source: TeleTrader)
more TeleTrader news

Russia claims its 2nd COVID vaccine is 100% effective

Russia's public health watchdog Rospotrebnadzor stated on Tuesday that the EpiVacCorona COVID-19 vaccine, the second jab that Moscow registered, has shown 100% efficacy in the clinical trials.

The assessment was based on the data acquired during the first two phases of the jab's clinical trial, the statement read.

The vaccine, developed by the Vector Institute, was registered in October and has entered the third phase of the trial a month later.

Breaking the News / BU